Insulin aspart, recombinant Subcutaneous and Midazolam nasal
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Midazolam nasal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: midazolam
Brand name: Versed, Nayzilam
Synonyms: Midazolam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Midazolam Nasal Spray
- Insulin aspart, recombinant Subcutaneous-Midazolam Syrup
- Insulin aspart, recombinant Subcutaneous-Midodrine
- Insulin aspart, recombinant Subcutaneous-Midodrine Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Midol
- Insulin aspart, recombinant Subcutaneous-Midol Caffeine Free
- Midazolam nasal-Insulin degludec
- Midazolam nasal-Insulin Degludec (U-100) Prefilled Pens
- Midazolam nasal-Insulin Degludec (U-100) Vials
- Midazolam nasal-Insulin Degludec (U-200) Prefilled Pens
- Midazolam nasal-Insulin degludec and liraglutide
- Midazolam nasal-Insulin degludec and liraglutide Subcutaneous